United Therapeutics Corporation (UTHR)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	300,000	500,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	800,000	600,000	750,000	800,000	1,050,000
Total assets	US$ in thousands	7,167,000	7,023,600	6,681,300	6,346,000	6,044,500	5,781,600	5,543,300	5,359,800	5,169,100	5,048,900	4,844,900	4,641,000	4,615,000	4,411,200	4,219,400	4,025,900	3,913,400	3,999,600	3,898,900	3,726,700
Debt-to-assets ratio		0.04	0.07	0.12	0.13	0.13	0.14	0.14	0.15	0.15	0.16	0.17	0.17	0.17	0.18	0.19	0.20	0.15	0.19	0.21	0.28

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $300,000K ÷ $7,167,000K
= 0.04

The debt-to-assets ratio of United Therapeutics Corp has shown a decreasing trend over the past eight quarters, starting at 0.15 in Q1 2022 and reaching 0.10 in Q4 2023. This indicates that the company has been successful in reducing its level of debt relative to its total assets over this period.

A lower debt-to-assets ratio suggests that the company is less reliant on debt financing to support its operations and has a stronger financial position. This can be a positive sign for investors and creditors, as it indicates lower financial risk and potentially higher financial stability.

It is worth noting that the decreasing trend in the debt-to-assets ratio may be a result of various factors, such as improved profitability, better cash flow management, or a strategic shift towards reducing debt levels. Overall, a decreasing debt-to-assets ratio can be viewed as a positive indicator of the company's financial health and prudent financial management.